Welcome to our dedicated page for HealWELL AI news (Ticker: HWAIF), a resource for investors and traders seeking the latest updates and insights on HealWELL AI stock.
HEALWELL AI Inc. (OTCQX: HWAIF; TSX: AIDX) regularly issues news updates as a healthcare artificial intelligence company focused on preventative care and early disease detection. Its announcements describe how the company is developing and commercializing proprietary clinical decision support systems and AI platforms intended to help healthcare providers detect rare and chronic diseases, improve efficiency, and support better patient outcomes.
News releases from HEALWELL cover a range of topics, including financial and operational updates, strategic acquisitions and divestments, and progress in integrating acquired businesses such as Orion Health. The company has reported a transition toward a pure-play digital SaaS, services and AI business focused on health systems and large enterprise customers, and its news flow reflects this emphasis on enterprise-grade healthcare software and data science offerings.
HEALWELL’s news also highlights developments in its AI platforms, including the DARWEN™ AI system and the launch of AmadeusAI, an AI-enabled digital care record built on Orion Health’s Amadeus platform. Announcements have described new AI tools such as SMARTSearch, SMARTSummary, and SMARTIdentify, as well as collaborations with public health organizations, healthcare systems, and life sciences partners.
Investors and observers can use this news page to follow HEALWELL’s disclosures on corporate transactions, joint ventures, memoranda of understanding, recognition of its AI technologies in peer-reviewed studies, and participation in industry and investment conferences. The updates provide context on how the company presents its strategy in preventative healthcare AI, its focus on real-world data and evidence generation, and its orientation toward large-scale health system and enterprise deployments.
HEALWELL AI (TSX:AIDX | OTCQX:HWAIF) will release Fiscal Q1 2026 results for the period ended March 31, 2026, after market close on Thursday, May 7, 2026. The company will host a conference call and simultaneous webcast on Friday, May 8, 2026 at 8:30 AM ET / 5:30 AM PT.
The call will be led by James Lee (CEO), Dr. Alexander Dobranowski (President) and Anthony Lam (CFO). Webcast and dial-in details are provided for live access.
HEALWELL AI (OTCQX: HWAIF) appointed Brad Porter to its Board of Directors effective April 22, 2026, strengthening commercial and strategic leadership.
Porter, HEALWELL chief commercial officer and CEO of Orion Health, brings over 15 years of finance and global healthcare technology experience. Ian McCrae is stepping down after the Orion Health integration.
HEALWELL (OTCQX:HWAIF) will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference in Toronto on April 21-22, 2026. Presentation: April 22, 2026, 2:00–2:30 PM ET. CEO James Lee and President Dr. Alexander Dobranowski will attend and hold one-on-one investor meetings.
The company will deliver a corporate presentation and take part in 1-on-1 meetings; investors should contact Bloom Burton representatives to schedule meetings.
HEALWELL AI (OTCQX: HWAIF) reported record fiscal 2025 results with $103.8M revenue, a 427% increase year-over-year, and its first full year of positive Adjusted EBITDA at $2.3M. The company reported an IFRS net loss of $39.1M and ended the year with $18.6M cash.
HEALWELL completed strategic divestments generating $9.7M in cash, integrated Orion Health, and highlighted DARWEN's scientific validation with 47 peer-reviewed publications.
HEALWELL AI (OTCQX:HWAIF) announced its 47th peer-reviewed publication validating the DARWEN™ AI platform, with new research published in the Journal of Crohn's and Colitis and presented at ECCO on March 12, 2026. HEALWELL also secured three additional 2026 conference acceptances across diabetes, dermatology and IBD.
The studies show DARWEN™ can transform unstructured EHR data into research-ready real-world evidence, analyze millions of clinical records, and support Medical Affairs and market access initiatives with pharmaceutical partners.
HEALWELL AI (TSX: AIDX) (OTCQX: HWAIF) will release its Fiscal Fourth Quarter and Year End 2025 financial results for the period ended December 31, 2025, on March 19, 2026. A conference call and simultaneous webcast to discuss results will be held on March 20, 2026 at 8:30 AM ET.
Management hosting the call: James Lee, Chief Executive Officer; Dr. Alexander Dobranowski, President; and Anthony Lam, Chief Financial Officer. Webcast and dial-in details provided for live access.
HEALWELL AI (OTCQX: HWAIF) announced a signed multi‑million dollar, multi‑year U.S. Health Information Exchange (HIE) software contract, expanding its enterprise interoperability footprint and supporting secure data exchange for millions of patient lives.
The company reported renewed pipeline momentum, coordinated Orion Health and VeroSource bid activity, and integration of SMART Identify, SMART Search and SMART Summary into the Amadeus AI platform to drive enterprise AI commercialization.
HEALWELL (OTCQX:HWAIF) will participate in three investor conferences in March 2026: TD Cowen (Boston, Mar 2-4), Scotiabank TMT (Toronto, Mar 3-4) and ROTH (Dana Point, Mar 22-24).
Dr. Alexander Dobranowski will present and hold investor meetings, including a TD Cowen presentation on Mar 3 and a ROTH panel on Mar 23 titled Technologies Advancing Healthy Aging.
HEALWELL AI (OTCQX:HWAIF) announced its first contracted AI deployment in the Middle East and expanded active deployments across Canada and the United States on February 26, 2026. The Company is deploying SMART Identify, SMART Search, and SMART Summary in multiple healthcare systems, marking cross‑border commercial momentum and platform scalability.
HEALWELL says deployments span frontline care environments and that contracted revenue now exists across Canada, the U.S., and the Middle East, while the company reports a growing pipeline for broader enterprise expansion.
HEALWELL AI (OTCQX: HWAIF) and WELL Health launched WELLTRUST™ on February 19, 2026, a consent-first data governance and patient-identification platform deployed across WELL-operated clinics in Canada. WELLTRUST uses patient-controlled consent and HEALWELL's DARWEN™ AI to identify high-fit patients for clinical trials while preserving privacy and compliance.
The platform supports contact consent, unified privacy controls, AI-enabled recruitment, and a governance layer to meet Canadian regulatory standards.